Vice President of Commercial – U.S. Generics, Biosimilars & 505(b)(2)

As Vice President of Commercial - U.S Generics, Biosimilars & 505(b)(2), you’ll lead the strategic development, launch, and growth of Lupin’s U.S. generics portfolio with a specialized focus on biosimilars and 505(b)(2) assets. This executive will drive market expansion, ensure profitable product positioning, and build commercial excellence across the organization. The VP/SVP will architect go-to-market strategies that enhance profitability, deepen market penetration, and position Lupin as a category leader. This role demands a forward-thinking enterprise builder who can translate deep market insight into cross-functional momentum.

Key Responsibilities

Strategic Leadership:

• Own and execute commercial strategies for U.S. generics, biosimilars, and 505(b)(2) assets, ensuring alignment with overall business objectives.
• Guide lifecycle management, pricing, and go-to-market planning for both pipeline and approved 505(b)(2)and generics products.
• Lead business development assessments for potential licensing, partnerships, and portfolio acquisitions within the 505(b)(2) and generics space.
• Collaboration & Alignment:
• Partner with Regulatory, R&D, Manufacturing, and Supply Chain teams to ensure commercial alignment and seamless execution of strategies for 505(b)(2) and generics products.
• Build strong relationships with wholesale distributors, pharmacy networks, GPOs, and payers to enhance market access and product uptake
• Market Intelligence & Competitive Analysis
• Monitor competitive intelligence, market trends, and reimbursement dynamics to inform strategic decisions and maintain a competitive edge in the 505(b)(2) and generics market.
• Oversee forecasting and budgeting processes for key therapeutic assets within the 505(b)(2) and generics portfolio.

Team Development & Leadership:

• Champion team development, culture building, and cross-functional collaboration to foster a high-performing and innovative team focused on 505(b)(2) and generics products.

Qualifications and Experience:

• Bachelor’s degree in Life Sciences or Business; MBA or equivalent preferred.
• 12 years of progressive commercial experience in generics, biosimilars, and/or 505(b)(2) pharmaceuticals.
• Deep understanding of the U.S. payer and provider landscape.
• Ability to navigate regulatory nuances specific to generics and hybrid pathways.
• Executive presence and a history of leading high-performing commercial teams.

Preferred Attributes:

• Experience with digital marketing and data-driven decision-making.
• Familiarity with 340B, 505B2, GPOs, and institutional customer segments.
• Ability to navigate ambiguity and drive results in a competitive market.
• Demonstrated success in launching and optimizing performance for complex assets.

The anticipated annual base salary range for this position in New Jersey is $300,000 to $3500,000, plus a discretionary performance bonus (based upon eligibility). The final salary offered to a successful candidate may vary and will be dependent on several factors that may include but are not limited to the type and length of experience within the job, the type and length of experience within the industry, skillset, education, business needs, etc. Lupin is a multi-state employer, and this salary range may not reflect positions that work in other states